Metraipolis › archive › dc_b8f043ff73a5

Antibody-Drug Conjugates Targeting Resistance-Associated Signaling Pathways: Recent Advances and Future Perspectives — Europe PMC PMID:41977464

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41977464
DOI
10.3390/ijms27073287
License (as archived)
solo-consultazione
Archived
2026-11-03T08:56:35.929Z
SHA-256 of the archived text
be8d45a10187f5a0952d9f3a8eaa93d40cfffb81477d0a49d701c63a4fea51c2
Stable URL of this page
https://metraipolis.com/documento/dc_b8f043ff73a5

How to cite

Antibody-Drug Conjugates Targeting Resistance-Associated Signaling Pathways: Recent Advances and Future Perspectives — Europe PMC PMID:41977464 — Europe PMC (en), https://europepmc.org/article/MED/41977464 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b8f043ff73a5 (Metraipolis archive dc_b8f043ff73a5, sha256 be8d45a10187f5a0952d9f3a8eaa93d40cfffb81477d0a49d701c63a4fea51c2)
BibTeX
@misc{dcb8f043ff73a5,
  title = {Antibody-Drug Conjugates Targeting Resistance-Associated Signaling Pathways: Recent Advances and Future Perspectives — Europe PMC PMID:41977464},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41977464},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b8f043ff73a5; sha256 be8d45a10187f5a0952d9f3a8eaa93d40cfffb81477d0a49d701c63a4fea51c2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41977464. Agents can read the archived copy with the MCP tool read_document.